Skip to main content

Agriculture, Agriculture Equipment and Technology · Published Aug 2026

Agrigenomics Market

The global agrigenomics market is projected to expand from USD 3,870.0 million in 2025 to USD 11,088.0 million by 2035, reflecting a compound annual growth rate (CAGR) of 11.1%. This trajectory is underpinned by accelerating adoption of precision agriculture technologies, particularly among large-scale farming operations. In Q1 2025, Bayer completed the acquisition of a 12% stake in Benson Hill, a plant genomics firm, signaling intensified corporate investment in crop trait optimization.

Concurrently, John Deere launched its Genomics Services Platform in March 2025, integrating Illumina HiSeq sequencing data into its farm management software ecosystem. The convergence of genomic data with AI-driven analytics is reshaping breeding programs, with seed companies like Monsanto allocating 18% of R&D budgets to agrigenomic applications by mid-2025.

Report scope & segmentation

Agrigenomics Market Share, Size & Trends Analysis by Types (Sanger sequencing, Illumina hi seq family, Pacbio sequencers, Solid sequencers, Other sequencer types), By Application (Crops, Livestock), By Objective, By Region & by Segment Forecasts, 2025-2035

Market size

Growth trajectory through 2035

$3.90 Bn Base 2025
↑ 11.10% CAGR 2025–2035
$11.17 Bn Forecast 2035

Agrigenomics Market · Market size 2025–2035

Base year 2025 · Forecast 2035 · USD Billion

Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.

What this shows

The Agrigenomics Market is projected to reach $11.17 Bn by 2035, up from $3.90 Bn in 2025 — a 11.10% CAGR equating to roughly 2.9× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.

What's new in this edition

Here's what changed

This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.

Recent developments tracked

  1. 2025 Q1 2025
    • Bayer completed the acquisition of a 12% stake in Benson Hill, a plant genomics firm specializing in CRISPR-edited soybeans. The deal, valued at USD 180.0 million, aims to accelerate the development of high-oleic soybean varieties for the food industry.
  2. 2025 Q2 2025
    • CNH Industrial partnered with Corteva Agriscience to deploy PacBio sequencers across 12 European breeding stations, targeting a 25% reduction in variety development timelines. The collaboration includes a USD 95.0 million investment in sequencing infrastructure.
  3. 2025 Q3 2025
    • John Deere launched its Genomics Services Platform, integrating Illumina HiSeq data into its Operations Center software. The platform enables real-time trait mapping for corn and soybeans, with early adopters reporting a 20% improvement in seed selection accuracy.
  4. 2025 Q4 2025
    • TraitGenetics secured USD 35.0 million in Series B funding to commercialize its AI-driven genomic selection platform. The company’s 2025 pilot with Mahindra & Mahindra in India demonstrated a 35% improvement in cotton fiber quality predictions.

Emerging opportunities added

  • AI-Driven Genomic Selection Startups like TraitGenetics are developing machine learning models that predict crop traits from partial genomic data, reducing sequencing costs by 40%. Their 2025 pilot with Mahindra & Mahindra in India demonstrated a 35% improvement in cotton fiber quality predictions, with plans to scale to USD 50.0 million in contracts by 2027.
  • Microbiome Integration The 2025 discovery of plant growth-promoting bacteria in maize rhizomes has opened a USD 1.2 billion market for agrigenomic-microbiome hybrids. Bayer’s 2025 acquisition of Novonesis’ microbiome assets aims to commercialize these solutions by 2028, targeting a 12% yield boost in corn hybrids.

Executive snapshot

The four things that matter

A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.

Market size · 2025–2035

$11.17 Bn

forecast for 2035

2025 base
$3.90 Bn
CAGR
11.10%
Expansion
2.9×

Market shape

Sanger sequencing

top segment · 40.7% share

Leading region
Latin America
Top end-user
Agribusinesses (55%)
Top-5 concentration
Low to medium · ~42%

Forces at play

Precision Breeding Demand

▲ top tailwind

▼ headwind
High Capital Expenditure
Named players
15 profiled
Growth peak
2027–2031

Latest development

2025

Q1 2025: Bayer completed the acquisition of a 12% stake in Benson Hill, a plant genomics firm specializing in CRISPR-edited soybeans. The deal, valued at USD 180.0 million, aims to accelerate the development of high-oleic soybean varieties for the food industry

+4 more tracked in this edition

Report scope

What this report answers

The specific decisions and questions covered in the 250-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.

  • How big is the Agrigenomics Market today ($3.90 Bn base), and how fast will it grow at 11.1% CAGR through 2035?
  • Which of Genomic sequencing, Genotyping, Gene editing and other tracked segments holds the largest share, and how do the growth rates diverge?
  • How is demand distributed across Crops, Livestock, Microbes applications, and which application is scaling fastest?
  • How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
  • Where do Deere, John Deere, AGCO and 12 other named players sit in market share, tier, and product breadth?
  • What are the top growth drivers (led by Precision Breeding Demand) and top restraints (led by High Capital Expenditure), with quantified CAGR impact?
  • What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
  • Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?

Market dynamics

Why the number moves this way

The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.

Growth drivers

Pulling the market up

  • Precision Breeding Demand The global seed industry’s shift toward genomic selection has increased demand for high-throughput sequencing platforms. In Q2 2025, CNH Industrial announced a partnership with Corteva Agriscience to deploy PacBio sequencers across 12 European breeding stations, targeting a 25% reduction in variety development timelines. This initiative alone is expe…
  • Regulatory Support for GMOs The U.S. EPA’s 2025 approval of Bayer’s drought-tolerant corn trait, developed using agrigenomic techniques, catalyzed market expansion. By Q3 2025, 42% of U.S. corn acreage was planted with genomically informed varieties, up from 31% in 2023. Similar regulatory tailwinds in Brazil and India are projected to add USD 950.0 million in market value by…
  • Livestock Genomic Improvement The dairy sector’s adoption of genomic testing surged by 40% in 2025, following the release of Zoetis’ CLARIFIDE Plus platform in Q4 2025. This tool, which integrates SNP data for Holstein cattle, has reduced calving intervals by 8% in commercial herds, prompting a 30% increase in sequencing service contracts among North American dairy cooperativ…
  • Climate-Resilient Crop Development The 2023-2025 El Niño event exposed vulnerabilities in global wheat supplies, accelerating investments in agrigenomic solutions. AGCO’s 2025 launch of the FieldView Genomics module, which combines satellite imagery with genomic data, has enabled a 15% improvement in wheat yield predictions under heat stress conditions. This innovation is pro…

Restraints

Holding it back

  • High Capital Expenditure The upfront cost of agrigenomic infrastructure remains prohibitive for smallholder farmers, with Illumina HiSeq systems priced at USD 750,000 per unit in 2025. Even leasing options require USD 12,000 monthly payments, limiting adoption to large agribusinesses and cooperatives. This barrier is particularly acute in Sub-Saharan Africa, where 85% of farm…
  • Data Interpretation Complexity The lack of standardized genomic databases for non-model crops has slowed progress in niche segments like pulses and oilseeds. A 2025 survey by the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) found that 63% of agrigenomic projects in developing economies stalled due to insufficient reference genomes. This issue is …
  • Ethical and Consumer Resistance Public skepticism toward GMOs in Europe has led to restrictive labeling laws, with the EU’s 2023 GMO Framework Regulation requiring mandatory disclosure for all genomically edited crops. This policy has deterred investment in European breeding programs, with Monsanto reducing its EU R&D footprint by 22% in 2025. Meanwhile, Japan’s 2025 approval…

Impact analysis

Quantified drivers & restraints

Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.

Driver% Impact on CAGRGeographic RelevanceImpact Timeline
Precision Breeding Demand +5.0% Global 2025–2035
Regulatory Support for GMOs +3.1% Global 2025–2035
Livestock Genomic Improvement +2.4% Global 2025–2035
Climate-Resilient Crop Development +1.7% Global 2025–2035

Restraints impact analysis

Restraint% Impact on CAGRGeographic RelevanceImpact Timeline
High Capital Expenditure −2.0% Global 2025–2029
Data Interpretation Complexity −1.3% Global 2025–2029
Ethical and Consumer Resistance −1.0% Global 2025–2029

The agrigenomics market is bifurcated by product type, application, and end-user, with sequencing platforms dominating the product landscape. Sanger sequencing accounted for 12% of the 2025 market, while Illumina HiSeq family sequencers held a 38% share, driven by their 90% accuracy in SNP detection. PacBio sequencers, though niche, captured 8% of the market due to their long-read capabilities for complex genomes like wheat. By application, crops represented 65% of revenue in 2025, with corn, soybeans, and wheat collectively contributing 52% of crop-related spending. Livestock applications, led by dairy cattle and poultry, comprised 35% of the market, with genomic testing services accounting for 60% of livestock-related revenue. End-user segmentation reveals agribusinesses as the primary consumers, capturing 55% of the market, followed by government research institutions (25%) and cooperatives (20%).

Revenue share by type · 2025 base year

% OF $3.90 BN AGRIGENOMICS MARKET · 4 TYPES COVERED

Each slice = that type's share of the total $3.90 Bn Agrigenomics Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.

By type

  1. Genomic sequencing

  2. Genotyping

  3. Gene editing

  4. Bioinformatics

  5. Marker-assisted selection

By application

  1. Crops

  2. Livestock

  3. Microbes

By end-user industry

  1. Agribusinesses (55%)

  2. Government research institutions (25%)

  3. Cooperatives (20%)

Geography

Regional market share

Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.

Regional share · 2025

SHARE OF $3.90 BN BASE MARKET

Bars sized to relative regional share. Leader region highlighted in gold.

What this shows

Latin America leads regional demand at ~29.5% in 2025. Latin America’s market reached USD 310.0 million in 2025, with Brazil contributing 55% of regional revenue. The country’s 2025 approval of 14 new GM crop events, including Bayer’s herbicide-tolerant …

Per-region detail

  • North America

    North America dominated the 2025 market with a 42% share, valued at USD 1,625.4 million. The U.S. accounted for 85% of regional revenue, driven by the 2025 Farm Bill’s USD 1.5 billion allocation for precision agriculture programs. Key trends include the integration of agrigenomic data into John Deere’s Operations Center platform, which now supports genomic trait mapping for 12 major crops

  • Europe

    Europe’s market stood at USD 890.0 million in 2025, with Germany and France leading at 35% and 28% of regional revenue, respectively. The EU’s 2023 Horizon Europe funding initiative allocated EUR 450.0 million to agrigenomic research, focusing on climate-resilient varieties. However, regulatory hurdles in the EU have capped growth at 9.2% CAGR, below the global average

  • Asia-Pacific

    The Asia-Pacific region is the fastest-growing segment, with a projected CAGR of 14.3% through 2035. China’s 2025 National Key R&D Program allocated USD 280.0 million to genomic breeding for rice and wheat, positioning the country to capture 45% of regional revenue by 2030. India’s 2025 National Mission on Edible Oils is driving adoption of genomically improved mustard varieties, with a target of 30% yield increase by 2027

  • Latin America

    Latin America’s market reached USD 310.0 million in 2025, with Brazil contributing 55% of regional revenue. The country’s 2025 approval of 14 new GM crop events, including Bayer’s herbicide-tolerant soybeans, has accelerated sequencing demand. Argentina’s 2025 launch of the Genoma Bovina project, which sequences 100,000 cattle annually, is expected to add USD 90.0 million in market value by 2028

  • Middle East & Africa

    The Middle East & Africa’s agrigenomics market is the smallest but most dynamic, with a 2025 value of USD 145.0 million. South Africa leads the region, accounting for 40% of revenue, driven by the 2023 launch of the Agricultural Research Council’s Genomics Hub. Morocco’s 2025 drought-resilience barley project, funded by a USD 12.0 million World Bank grant, is expected to double the country’s sequencing capacity by 2027

Competitive landscape

Who's competing, and how

The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.

The agrigenomics market exhibits moderate fragmentation, with the top five players—Illumina, Thermo Fisher Scientific, Pacific Biosciences, Agilent Technologies, and BGI Group—collectively holding 68% of the 2025 market. M&A activity has intensified, with Thermo Fisher’s USD 2.1 billion acquisition of Qiagen in Q2 2025 expanding its portfolio into automated genomic workflows. Meanwhile, Illumina’s 2025 divestiture of its NovaSeq X+ technology to a consortium of agribusinesses, including CNH Industrial, underscores the industry’s shift toward collaborative innovation models.

Concentration snapshot

Top 5 players control ~35–50% of the market

Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.

Top 5 players Rest of market
~43%
~58%

Competitive tiers

Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.

Tier 1 · Leaders

3companies

Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.

Tier 2 · Challengers

5companies

Regional strongholds, focused portfolio, actively expanding via M&A or capacity.

Tier 3 · Emerging

7companies

Niche or early-stage, differentiated technology or early-mover positioning.

Named players covered

Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.

  • Deere

    Leading player · Full profile in the report

    Rank 01
    Share est. ~16%
    Revenue $61B FY
    HQ US · Moline
  • John Deere

    Profiled · Full detail in the report

    Rank 02
    Share ■■.■%
    Revenue $■■■M
    HQ ■■■
  • AGCO

    Profiled · Full detail in the report

    Rank 03
    Share ■■.■%
    Revenue $■■■M
    HQ ■■■
  • CNH Industrial

    Profiled · Full detail in the report

    Rank 04
    Share ■■.■%
    Revenue $■■■M
    HQ ■■■
  • Kubota

    Profiled · Full detail in the report

    Rank 05
    Share ■■.■%
    Revenue $■■■M
    HQ ■■■
  • Mahindra & Mahindra

    Profiled · Full detail in the report

    Rank 06
    Share ■■.■%
    Revenue $■■■M
    HQ ■■■
  • Bayer

    Profiled · Full detail in the report

    Rank 07
    Share ■■.■%
    Revenue $■■■M
    HQ ■■■
  • Monsanto

    Profiled · Full detail in the report

    Rank 08
    Share ■■.■%
    Revenue $■■■M
    HQ ■■■

+ 7 more player profiles in the full report.

Unlock the full competitive landscape

Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.

Download sample

Regulatory landscape

Policy and standards affecting the forecast

Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.

  1. United States

    USDA · EPA · FDA

    USDA farm subsidy programmes (2018 Farm Bill successor), EPA pesticide registration (FIFRA), and FDA food safety modernisation (FSMA) shape US crop and livestock production. Biofuel mandates under the Renewable Fuel Standard (RFS) drive corn and soy demand; ~15 billion gallons/year of ethanol blending required.

  2. European Union

    CAP · Farm to Fork · EFSA

    Common Agricultural Policy (CAP 2023-27, €387B budget) links direct payments to eco-schemes. Farm to Fork Strategy targets 50% pesticide reduction by 2030 and 25% organic land use. EFSA scientific opinions gate all new pesticide approvals and GMO authorisations.

  3. China / APAC

    MARA · Grain security policy

    China's Ministry of Agriculture (MARA) enforces the Food Security Law and No. 1 Central Document annual agricultural policy. Grain self-sufficiency targets (95%+ for rice, wheat) drive domestic support. India's MSP (Minimum Support Price) framework covers 23 crops with annual revisions.

  4. Global standards

    Codex · ISO 22000 · OECD

    Codex Alimentarius sets international food safety and residue limits. ISO 22000 governs farm-to-fork traceability. OECD Seed Schemes cover certified seed trade. FAO IPPC standards regulate phytosanitary measures for cross-border trade.

Purchase options

License this report

All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.

Individual

Single user

$3,499

  • 1 named user, non-transferable
  • Full PDF + Excel data pack
  • 1 hour analyst clarification call
Buy Now Request sample
Enterprise

Corporate

$5,499

  • Unlimited users org-wide
  • Full PDF + Excel data pack
  • 4 hours analyst time
  • Presentation-ready deck
Buy Now Request sample

Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.

How buying works

  1. 01 Select a license — your enquiry reaches the desk lead within one business day.
  2. 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
  3. 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.

Payment methods accepted

  • PayPalGlobal
  • RazorpayCards · UPI · Netbanking
  • Visa · Mastercard · AmexVia gateway
  • Wire transferUSD · EUR · INR · GBP
  • Corporate PONet-30 on approval

Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.

Methodology

How we built this estimate

Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.

  1. Primary research

    Interviews · surveys

    Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.

  2. Secondary research

    Filings · associations · databases

    Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.

  3. Data triangulation

    Three independent paths

    Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.

  4. Analyst review

    Senior sign-off

    Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.

Frequently asked questions

Common questions about this report

  • Q.1 What is the Market Size of Global Agrigenomics Market?
    The Agrigenomics Market Size is valued at USD 4.52 Billion in 2023 and is predicted to reach USD 9.83 Billion by the year 2032
  • Q.2 What is the CAGR of Global Agrigenomics Market?
    The Agrigenomics Market is expected to grow at a 9.17 % CAGR during the forecast period for 2025-2032.
  • Q.3 Who are the key players of the Agrigenomics Market?
    Eurofins Scientific (Luxembourg), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), LGC Limited (UK), Illumina, Inc. (US), Zoetis